Clinical Trial

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

Study acronym: BPII-DEP-LT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the efficacy and safety of light therapy for the treatment of bipolar type II patients relapsing into a depressive phase during autumn or winter.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2007-12-26; most recent amendment 2024-08-05.
Status change: Recruiting → Active, Not Recruiting 2023-02-17
Status change: Not Yet Recruiting → Recruiting 2008-01-22
Trial Details
NCT Number NCT00590265
Lead Sponsor Douglas Mental Health University Institute
Collaborators: National Alliance for Research on Schizophrenia and Depression
Conditions Bipolar Type II Disorder, Depression, Bipolar
Enrollment 50 participants
Start Date 2008-01
Primary Completion 2025-06 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2024-08-07